Skip to main content
HR 3550 109th Congress House Health Administrative procedure Communication in medicine Communication in science Conferences Congress Congressional reporting requirements Department of Health and Human Services Economics and Public Finance Environmental Protection Environmentally induced diseases Epidemiology Executive reorganization Federal aid to research Government Operations and Politics Governmental investigations Law Medical research Medical statistics National Institutes of Health (NIH)

Morris K. Udall Parkinson's Disease Research Act Amendments of 2005

Introduced: July 28, 2005 See on congress.gov
This bill died when the 109th Congress ended
It never became law before the 109th Congress (2005–2006) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 5, 2005
Referred to the Subcommittee on Health.
Jul 28, 2005
Referred to the House Committee on Energy and Commerce.
Jul 28, 2005
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Morris K. Udall Parkinson's Disease Research Act Amendments of 2005 - Amends the Public Health Service Act to revise provisions regarding a research planning conference required to be convened by the Director of the National Institutes of Health (NIH) to require such conference to: (1) investigate Parkinson's research funded by NIH; and (2) identify shortcomings and opportunities for more effective treatments and a cure for Parkinson's disease.

Requires the result of each conference to be included in a research investment plan that also: (1) provides for measurable results with the goals of better treatments and a cure for Parkinson's disease determining the allocation of research dollars; (2) includes an outline of how to fully utilize the Udall Center program; and (3) includes a budget and implementation strategy.

Requires the Secretary of Health and Human Services to ensure adequate funding to carry out activities described in the investment plan.

Requires the Director to ensure funding for an additional Morris K. Udall research center to coordinate activities conducted by, and manage the interdisciplinary efforts of, the other centers. Requires each research center to ensure that there is a significant clinical component and ongoing basic research. Requires the Director to establish an application review process for grants to fund such research centers. Directs (currently, allows) the Director to award grants to support qualified investigators with potential for significant future Parkinson's disease breakthroughs.

Requires the Director to investigate and report to Congress on the incidence of Parkinson's disease.

What's happening now August 5, 2005

Referred to the Subcommittee on Health.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3550: Morris K. Udall Parkinson's Disease Research Act Amendments of 2005. 109th Congress. Open America. https://openamerica.io/bill/109-HR-3550/
MLA
"H.R. 3550: Morris K. Udall Parkinson's Disease Research Act Amendments of 2005." 109th Congress, 2026, Open America, https://openamerica.io/bill/109-HR-3550/.
Bluebook (legal)
H.R. 3550, 109th Cong. (2026), https://openamerica.io/bill/109-HR-3550/.
Markdown link
[H.R. 3550: Morris K. Udall Parkinson's Disease Research Act Amendments of 2005](https://openamerica.io/bill/109-HR-3550/)
Report a problem